Governor Ed Rendell Joins Pennsylvania Cancer Alliance In Honoring House Speaker Matthew J. Ryan
PHILADELPHIA (January 28, 2003) — Governor Edward G. Rendell will join the Pennsylvania Cancer Alliance in honoring the Honorable Matthew J. Ryan (R-Delaware and Chester Counties), Speaker of the Pennsylvania House of Representatives, during a reception on Tuesday, January 28th, in Harrisburg at the Whitaker Center's Amp Grand Lobby at 5:00 p.m. The Alliance will recognize Ryan's support of cancer research in Pennsylvania.
In 2003, some 70,000 Pennsylvanians will be diagnosed with cancer and 30,000 Pennsylvanians will die from the disease. Cancer patients, survivors and their families face a challenging and uncertain future. Through Ryan's leadership, a significant portion of the tobacco Master Settlement Agreement funds were designated for healthcare initiatives, including critical cancer research at Pennsylvania Cancer Alliance institutions.
The Pennsylvania Cancer Alliance is dedicated to reducing the burden of cancer on the citizens of the Commonwealth of Pennsylvania by pursuing world-class basic and clinical research to improve cancer prevention and advance the standard of cancer care available statewide. The members of the Alliance are: Drexel University/MCP Hahnemann University, Philadelphia; Fox Chase Cancer Center, Philadelphia; Pennsylvania State University, Hershey; Temple University, Philadelphia; Thomas Jefferson University, Philadelphia; University of Pennsylvania, Philadelphia; University of Pittsburgh, Pittsburgh; and The Wistar Institute, Philadelphia.
Organized in 1998, the Pennsylvania Cancer Alliance set as one of its first goals the task of communicating to Commonwealth legislators the need to allocate a substantial portion of the funds from that year's national tobacco settlement to research and prevention of diseases directly linked to tobacco use, including cancer. Under Ryan's leadership, the State House voted to designate money for health related issues, and Pennsylvania is today a national leader in the fight against cancer and other top killers.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).